MDGS dividend history
Medigus Ltd. (MDGS) dividend declarations and ex-dividend dates - real-time wire coverage of every payout disclosure.
Recent dividend items
- Medigus Announces Record 2022 First Half Financial ResultsTEL AVIV, Israel, Sept. 23, 2022 (GLOBE NEWSWIRE) -- Medigus Ltd. (NASDAQ:MDGS) ("Medigus"), a technology company engaged in advanced medical solutions, innovative internet technologies and electric vehicle and charging solutions, today reported financial results for the six months ended June 30, 2022. Key Highlights Generated record revenues of $34.95 million in the first half of 2022, compared to $2.39 million revenues in the first half of 2021Gross profit reached a record $6.19 million in the first half of 2022, up from a gross profit of $0.6 million in the first half of 2021Cash and cash equivalents as of June 30, 2022 were $22.1 millionShareholders' equity improved to $53.19 million
- Medigus Board Files a Motion to Approve an Up to $1.6 Million Dividend DistributionTel Aviv, Israel, Sept. 08, 2022 (GLOBE NEWSWIRE) -- Medigus Ltd. (NASDAQ:MDGS), a technology company engaged in advanced medical solutions, innovative internet technologies, and electric vehicle and charging solutions, announced today that the Company filed a motion with the Tel Aviv District Court Economic Department for approval of a dividend distribution up to of $1.6 million. The Company's motion, if approved as requested, would permit the Company to distribute a dividend to the holders of the Company's American Depositary Shares in proportion to their respective holdings. A separate announcement would be made if the Company's board of directors were to declare such a dividend.
- Medigus: Increases Holdings in Gix to Approximately 36.7% on a Fully Diluted BasisOMER, Israel, July 07, 2021 (GLOBE NEWSWIRE) -- Medigus Ltd. (NASDAQ:MDGS), a technology company engaged in advanced medical solutions and innovative internet technologies, today announced that it exercised all of its rights to convert Linkury Ltd. shares to Gix Internet Ltd. shares (TASE: GIX) and was issued 3,954,980 additional ordinary shares of Gix such that following the conversion, Medigus holds approximately 36.7% on a fully diluted basis of Gix outstanding capital. In March 2021, Gix's board of directors has resolved to establish a committee of the board of directors to identify new opportunities and activities to merge with Gix, focusing on technology and other sectors that are
- Medigus: Gix Internet Announced that its Board of Directors Resolved to Identify New Opportunities and Activities for a MergerGix Internet will consolidate its ad-tech operations under its subsidiary Linkury Ltd. OMER, Israel, March 31, 2021 (GLOBE NEWSWIRE) -- Medigus Ltd. (Nasdaq: MDGS), a technology company engaged in advanced medical solutions and innovative internet technologies, today announced that Gix Internet (24.99%) (TASE: GIX), a global marketing technology (MarTech) solutions company for online performance-based-marketing, announced several business updates. Gix Internet’s board of directors has resolved to establish a committee of the board of directors to identify new opportunities and activities to merge with Gix, focusing on technology and other sectors, that are not necessarily in the